Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain

By Araki T.   Tanji H.   Kato H.   Imai Y.   Mizugaki M.   Itoyama Y.  

European Neuropsychopharmacology, Vol. 10, Iss. 5, 2000-09 ,pp. : 365-375

Elsevier

Access to resources Recommend Favorite

Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle

By De Wit M.J.   Araki T.   Tanji H.   Kato H.   Mizugaki M.   Itoyama Y.  

European Journal of Pharmaceutical Sciences, Vol. 8, Iss. 4, 1999-08 ,pp. : 261-267

Elsevier

Access to resources Recommend Favorite

Effects of perinatal exposure to 9 -tetrahydrocannabinol on operant morphine-reinforced behavior

By Gonzalez B.   de Miguel R.   Martin S.   Perez-Rosado A.   Romero J.   Garcia-Lecumberri C.   Fernandez-Ruiz J.   Ramos J.A.   Ambrosio E.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 3, 2003-06 ,pp. : 577-584

Elsevier

Access to resources Recommend Favorite

Changes in rat brain energetic metabolism after exposure to anandamide or 9 -tetrahydrocannabinol

By Costa B.   Colleoni M.  

European Journal of Pharmacology, Vol. 395, Iss. 1, 2000-04 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Hypofrontality does not occur with 6-hydroxydopamine lesions of the medial prefrontal cortex in rat brain

By Kurachi M.   Yasui S.-I.   Kurachi T.   Shibata R.   Murata M.   Hagino H.   Tanii Y.   Kurata K.   Suzuki M.   Sakurai Y.  

European Neuropsychopharmacology, Vol. 5, Iss. 1, 1995-03 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite